3,4-Dimethoxycinnamic acid (O-Methylferulic acid) |CAS 2316-26-9|DC Chemicals

Cas No.:	2316-26-9
Chemical Name:	3,4-Dimethoxycinnamic acid
Synonyms:	3-(3,4-Dimethoxyphenyl)acrylic acid;(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoic acid;Caffeic acid dimethyl ether;3,4-Dimethoxycinnamic acid, predominantly trans;(E)-3-(3,4-Dimethoxyphenyl)-2-propenoic acid;3,4-DIMETHOXYCINNAMIC ACID;3.4-Dimethoxycinnamicacid;Dimethylcaffeic acid;DIMETHYLCAFFEIC ACID(P);DIMETHYLCAFFEIC ACID(RG);3-(3,4-Dimethoxyphenyl)-2-propenoic Acid;3,4-Dimethoxy;3,4-Dimethoxycinnami;Methylferulic acid;o-Methylferulic acid;RARECHEM BK HC T253;[ "" ];O-Methylferulic acid;3,4-Dimethoxycinnamic acid;2-Propenoic acid, 3-(3,4-dimethoxyphenyl)-;KBio1_001745;DivK1c_006801;3-(3,4-Dimethoxy-phenyl)acrylic acid;KBio2_000836;3-(3,4-dimethoxy-phenyl)-acrylic acid;3-(3,4-dimethoxyphenyl)-2-propenic acid;SY007353;KBioGR_002042;KBio3_001172;SPBio_000364;HJBWJAPEBGSQPR-UHFFFAOYSA-N;CHEBI:193396;3-(3,4-dimethoxyphenyl)acrylic acid;Spectrum_000356;KBio2_003404;FT-0614344;3,4-Dimethoxycinnamic Acid3,;Spectrum3_000256;KBioSS_000836;3,4-Dimethoxy cinnamic acid;AKOS017268657;3-(3,4-dimethoxyphenyl)-acrylic acid;NS00085552;KBio2_005972;SY031100;FT-0774117;Spectrum2_000412;Spectrum4_001551;DTXSID10871869;3-(3,4-dimethoxyphenyl)prop-2-enoic acid;SpecPlus_000705;FT-0667235
SMILES:	O=C(O)/C=C/C1=CC=C(OC)C(OC)=C1
Formula:	C₁₁H₁₂O₄
M.Wt:	208.21058
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.